Sunovion Pharmaceuticals Inc.

Covis Pharma Gmbh

Sepracor, Inc.

Paul Mcglynn

Roger P Bakale

H Scott Wilkinson

William K McVicar

Craig R Abolin

Andrea Bauer

Ulrich Bildmann

Helgert Müller

Renate Engelstätter

Craig Sturge

William K Mcvicar

This invention relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children. The aerosol composition comprises ciclesonide, ethanol and either 1,1,1,2-tetrafluoroethane, or 1,1,1,2,3,3,3-heptafluoropropane.

Pharmaceutical aerosol product for administration by oral or nasal inhalation

This invention relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children. The aerosol composition comprises ciclesonide, ethanol and either 1, 1, 1, 2-tetrafluoroethane, or 1, 1, 1, 2, 3, 3, 3-heptafluoropropane.

The inventive subject matter relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children.

The compound of formula (I) is a water-stable, long acting &#x3b2;-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.

Acetamide stereoisomer

The compound of formula (I) is a water-stable, long acting &#x3b2;-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.

Growing community of inventors

Northborough, MA, United States of America

Paul Mcglynn